A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis
Clinical trial NCT03630939 · COMPLETED
Trial details
- NCT number
- NCT03630939
- Sponsor
- Escalier Biosciences B.V.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-09
- Primary completion
- 2019-06-05
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.